Leitzel K - Search Results

1

Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy.

Vo MN, Evans M, Leitzel K, Ali SM, Wilson M, Demers L, Evans DB, Lipton A. Vo MN, et al. Among authors: leitzel k. Breast Cancer Res Treat. 2010 Feb;119(3):767-71. doi: 10.1007/s10549-008-0261-5. Epub 2008 Dec 30. Breast Cancer Res Treat. 2010. PMID: 19115106 Clinical Trial.

2

Elevated bone turnover predicts for bone metastasis in postmenopausal breast cancer: results of NCIC CTG MA.14.

Lipton A, Chapman JA, Demers L, Shepherd LE, Han L, Wilson CF, Pritchard KI, Leitzel KE, Ali SM, Pollak M. Lipton A, et al. J Clin Oncol. 2011 Sep 20;29(27):3605-10. doi: 10.1200/JCO.2010.31.5069. Epub 2011 Aug 22. J Clin Oncol. 2011. PMID: 21859992 Clinical Trial.

3

Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer.

Ali SM, Leitzel K, Chinchilli VM, Engle L, Demers L, Harvey HA, Carney W, Allard JW, Lipton A. Ali SM, et al. Among authors: leitzel k. Clin Chem. 2002 Aug;48(8):1314-20. Clin Chem. 2002. PMID: 12142389 Clinical Trial.

4

Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy.

Lipton A, Leitzel K, Ali SM, Demers L, Harvey HA, Chaudri-Ross HA, Evans D, Lang R, Hackl W, Hamer P, Carney W. Lipton A, et al. Among authors: leitzel k. Cancer. 2005 Jul 15;104(2):257-63. doi: 10.1002/cncr.21202. Cancer. 2005. PMID: 15952182 Free article.

5

Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer.

Souder C, Leitzel K, Ali SM, Demers L, Evans DB, Chaudri-Ross HA, Hackl W, Hamer P, Carney W, Lipton A. Souder C, et al. Among authors: leitzel k. Cancer. 2006 Nov 15;107(10):2337-45. doi: 10.1002/cncr.22255. Cancer. 2006. PMID: 17048231 Free article. Clinical Trial.

6

Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer.

Lipton A, Ali SM, Leitzel K, Demers L, Evans DB, Hamer P, Brown-Shimer S, Pierce K, Carney W. Lipton A, et al. Among authors: leitzel k. Cancer. 2007 May 15;109(10):1933-9. doi: 10.1002/cncr.22637. Cancer. 2007. PMID: 17407159 Free article. Clinical Trial.

7

Serum TIMP-1 and response to the aromatase inhibitor letrozole versus tamoxifen in metastatic breast cancer.

Lipton A, Leitzel K, Chaudri-Ross HA, Evans DB, Ali SM, Demers L, Hamer P, Brown-Shimer S, Pierce K, Gaur V, Carney W. Lipton A, et al. Among authors: leitzel k. J Clin Oncol. 2008 Jun 1;26(16):2653-8. doi: 10.1200/JCO.2007.15.4336. Epub 2008 Apr 28. J Clin Oncol. 2008. PMID: 18443351 Clinical Trial.

8

Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab.

Lipton A, Köstler WJ, Leitzel K, Ali SM, Sperinde J, Weidler J, Paquet A, Sherwood T, Huang W, Bates M; Trastuzumab Response Biomarker Group. Lipton A, et al. Among authors: leitzel k. Cancer. 2010 Nov 15;116(22):5168-78. doi: 10.1002/cncr.25430. Cancer. 2010. PMID: 20661914 Free article.

9

Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy.

Lipton A, Leitzel K, Ali SM, Carney W, Platek G, Steplewski K, Westlund R, Gagnon R, Martin AM, Maltzman J. Lipton A, et al. Among authors: leitzel k. Cancer. 2011 Nov 1;117(21):5013-20. doi: 10.1002/cncr.26101. Epub 2011 Mar 31. Cancer. 2011. PMID: 21456017 Free article.

10

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer.

Lipton A, Goodman L, Leitzel K, Cook J, Sperinde J, Haddad M, Köstler WJ, Huang W, Weidler JM, Ali S, Newton A, Fuchs EM, Paquet A, Singer CF, Horvat R, Jin X, Banerjee J, Mukherjee A, Tan Y, Shi Y, Chenna A, Larson J, Lie Y, Sherwood T, Petropoulos CJ, Williams S, Winslow J, Parry G, Bates M. Lipton A, et al. Among authors: leitzel k. Breast Cancer Res Treat. 2013 Aug;141(1):43-53. doi: 10.1007/s10549-013-2665-0. Breast Cancer Res Treat. 2013. PMID: 23959396 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters